海信視像(600060.SH):擬參與設立產業基金
格隆匯5月10日丨海信視像(600060.SH)公佈,擬作為有限合夥人,以自有資金與海信家電集團股份有限公司、海信集團控股股份有限公司、青島產業發展投資有限責任公司、青島億洋創業投資管理有限公司等共計7名法人合夥人,以及賈少謙、於芝濤、劉鑫、代慧忠等共計12名自然人合夥人簽訂合夥協議,共同出資發起設立青島奧宸私募股權投資基金合夥企業(有限合夥)。本基金合計認繳出資額為人民幣100,000萬元;其中本公司認繳出資額為17,000萬元,佔本基金份額的17%。本基金由億洋投資擔任基金管理人。主要投資領域包括但不限於智能製造、人工智能、集成電路、新一代信息技術等領域,以及與之相關的產業鏈上下游產業等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.